IL50413A - 2-benzoyl-3-phenylbenzothiophene (or benzothiophene oxide)derivatives - Google Patents

2-benzoyl-3-phenylbenzothiophene (or benzothiophene oxide)derivatives

Info

Publication number
IL50413A
IL50413A IL50413A IL5041376A IL50413A IL 50413 A IL50413 A IL 50413A IL 50413 A IL50413 A IL 50413A IL 5041376 A IL5041376 A IL 5041376A IL 50413 A IL50413 A IL 50413A
Authority
IL
Israel
Prior art keywords
phenylbenzothiophene
benzoyl
derivatives
benzothiophene oxide
benzothiophene
Prior art date
Application number
IL50413A
Other languages
English (en)
Other versions
IL50413A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL50413A0 publication Critical patent/IL50413A0/xx
Publication of IL50413A publication Critical patent/IL50413A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL50413A 1975-10-28 1976-09-05 2-benzoyl-3-phenylbenzothiophene (or benzothiophene oxide)derivatives IL50413A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62600975A 1975-10-28 1975-10-28

Publications (2)

Publication Number Publication Date
IL50413A0 IL50413A0 (en) 1976-11-30
IL50413A true IL50413A (en) 1980-05-30

Family

ID=24508577

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50413A IL50413A (en) 1975-10-28 1976-09-05 2-benzoyl-3-phenylbenzothiophene (or benzothiophene oxide)derivatives

Country Status (27)

Country Link
US (1) US4075227A (cs)
JP (1) JPS5253852A (cs)
AR (1) AR216451A1 (cs)
AT (1) AT352709B (cs)
AU (1) AU509682B2 (cs)
BE (1) BE847718A (cs)
BG (1) BG27554A3 (cs)
CA (1) CA1064031A (cs)
CH (1) CH626360A5 (cs)
CS (1) CS196328B2 (cs)
DD (1) DD127463A5 (cs)
DE (1) DE2647864C2 (cs)
DK (1) DK484576A (cs)
ES (1) ES452737A1 (cs)
FR (1) FR2329270A1 (cs)
GB (1) GB1572506A (cs)
GR (1) GR62400B (cs)
IE (1) IE43970B1 (cs)
IL (1) IL50413A (cs)
MX (1) MX3972E (cs)
NL (1) NL7611972A (cs)
NZ (1) NZ182428A (cs)
PL (1) PL109366B1 (cs)
PT (1) PT65753B (cs)
RO (1) RO70768A (cs)
SE (1) SE427035B (cs)
ZA (1) ZA766442B (cs)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
US4436748A (en) 1980-10-20 1984-03-13 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4528399A (en) * 1981-04-22 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. Benzo[b]thiophenes intermediates
US5354861A (en) * 1992-11-04 1994-10-11 National University Of Singapore 2-(benzyl)-3-arylbenzofurans as antitumour and hypocholesterolemic agents
IL109990A (en) * 1993-06-21 1999-06-20 Lilly Co Eli Materials and methods for screening anti-osteoporosis agents
US5523416A (en) * 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
US5552401A (en) * 1995-02-28 1996-09-03 Eli Lilly And Company 2-benzyl-3-arylbenzothiophenes
ZA9710262B (en) * 1996-11-19 1999-05-13 Lilly Co Eli Process for the synthesis of benzothiophenes
US6107346A (en) * 1997-08-11 2000-08-22 Eli Lilly And Company Methods for treating hyperlipidemia
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
AU776196B2 (en) * 1999-10-04 2004-09-02 Nippon Soda Co., Ltd. Phenolic compounds and recording materials containing the same
AU2002230409A1 (en) * 2000-11-27 2002-06-03 Eli Lilly And Company Process for preparing 3-aryl-benzo(b)thiophenes
AUPR283801A0 (en) * 2001-02-01 2001-03-01 Australian National University, The Chemical compounds and methods
AU2002241328B2 (en) * 2001-04-04 2005-01-20 Nippon Soda Co., Ltd. Recording material and recording sheet
US6962928B2 (en) * 2001-05-22 2005-11-08 Eli Lilly And Company Tetrahydroquinoline derivatives for the inhibition of osteoporosis, estrogen dependent breast cancer, endometriosis and uterine fibrosis
EP1395563B1 (en) * 2001-05-22 2006-03-29 Eli Lilly And Company 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
DE10309645A1 (de) * 2003-03-06 2004-09-16 Basf Ag Verfahren zur Herstellung von a-(3-Arylthio)-acetophenonen
KR20190117582A (ko) 2017-02-10 2019-10-16 쥐원 쎄라퓨틱스, 인크. 벤조티오펜 에스트로겐 수용체 조정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US3947470A (en) * 1974-06-20 1976-03-30 Smithkline Corporation Substituted benzofurans and benzothiophenes
US4001426A (en) * 1974-10-17 1977-01-04 Smithkline Corporation Substituted benzofurans and benzothiophenes
US3983245A (en) * 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes

Also Published As

Publication number Publication date
FR2329270A1 (fr) 1977-05-27
PL109366B1 (en) 1980-05-31
DD127463A5 (cs) 1977-09-28
IL50413A0 (en) 1976-11-30
GR62400B (en) 1979-04-10
PT65753B (en) 1978-04-20
SE427035B (sv) 1983-02-28
CA1064031A (en) 1979-10-09
DK484576A (da) 1977-04-29
CS196328B2 (en) 1980-03-31
NZ182428A (en) 1978-11-13
AU1740876A (en) 1978-03-09
BE847718A (fr) 1977-04-28
ATA800776A (de) 1979-03-15
ES452737A1 (es) 1978-01-01
DE2647864C2 (de) 1985-04-25
AT352709B (de) 1979-10-10
SE7611954L (sv) 1977-04-29
ZA766442B (en) 1978-06-28
JPS61344B2 (cs) 1986-01-08
AU509682B2 (en) 1980-05-22
GB1572506A (en) 1980-07-30
IE43970B1 (en) 1981-07-15
BG27554A3 (en) 1979-11-12
RO70768A (ro) 1982-10-26
PT65753A (en) 1976-11-01
NL7611972A (nl) 1977-05-02
AR216451A1 (es) 1979-12-28
JPS5253852A (en) 1977-04-30
DE2647864A1 (de) 1977-05-12
US4075227A (en) 1978-02-21
FR2329270B1 (cs) 1979-07-27
IE43970L (en) 1977-04-28
MX3972E (es) 1981-10-20
CH626360A5 (cs) 1981-11-13

Similar Documents

Publication Publication Date Title
GB1520812A (en) Benzhydrylsulphinyl derivatives
IL50413A (en) 2-benzoyl-3-phenylbenzothiophene (or benzothiophene oxide)derivatives
GB1549837A (en) Mechanisms
GB1557482A (en) Substituted tetranorprostaglandins
JPS5196648A (en) ******** ***o**
AU1597876A (en) Ortho-aminobutyrophenone derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
AU1074176A (en) Oxadiazolinone derivatives
CY1151A (en) Cis-bicyclooctyl-alkyl-amine derivatives
JPS5265276A (en) Substituted tetraalkylpiperidinee44oxime
AU1735076A (en) Substituted sulfoximides
GB1486104A (en) Phthalimidopiperidine derivatives
CS20076A2 (en) Volic napeti k seskupovani elektrickych topnych odporu
AU1661376A (en) Morphanthridine derivatives
JPS5190671A (en) Hisetsuchaku hokyobutsu o mochiiru hokyoyoki
JPS5191348A (en) Hozonsei o jusuru yudemenrui no seizoho
JPS5197279A (en) ****** ***o******
GB1520011A (en) Benodioxole derivatives
IL50535A0 (en) Substituted tetrahydroiminobenzo(b)thien-4-ylureas
ZA765655B (en) Substituted tetrahydroiminobenzo(b)thien-4-ylureas
JPS5195475A (en) Hatsuhoshiito o mochiiru kyokona hokyoyoki no seizoho
JPS51100948A (en) i gatakokatamenjidoyosetsusochi
JPS5181254A (en) Metaruchuku o ringunoshimeshirochoseihoho
JPS5198196A (en) Byoninno yobuni benki o sashiireruhoho
AU1190476A (en) Retaining mechanism